AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹14,670 Cr | ₹12,480 Cr | ₹11,573 Cr | ₹9,966 Cr | ₹9,888 Cr |
What is the latest Net Current Assets ratio of AUROBINDO PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹14,670 Cr |
| Mar2025 | ₹12,480 Cr |
| Mar2024 | ₹11,573 Cr |
| Mar2023 | ₹9,966 Cr |
| Mar2022 | ₹9,888 Cr |
How is Net Current Assets of AUROBINDO PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹14,670 Cr | 17.54 | |
| Mar2025 | ₹12,480 Cr | 7.84 | |
| Mar2024 | ₹11,573 Cr | 16.12 | |
| Mar2023 | ₹9,966 Cr | 0.79 | |
| Mar2022 | ₹9,888 Cr | - | |
Compare Net Current Assets of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹97,645.4 Cr | 3.4% | 4.8% | 57.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,437.0 Cr | -0.5% | -3% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,054.0 Cr | 1.6% | 9.3% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,842.0 Cr | 3.5% | 2.3% | 40.6% | Stock Analytics | |
| CIPLA | ₹111,565.0 Cr | 1.6% | -3.2% | -11.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,163.0 Cr | 5.8% | 3.2% | -8.3% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 3.4% |
4.8% |
57.3% |
| SENSEX | 0.7% |
-3.9% |
-8.9% |
You may also like the below Video Courses